|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-28
|
|
pubmed:abstractText |
To test the hypothesis that the APOE epsilon4 allele is associated with the clinical manifestations of AD through an association with the pathologic hallmarks of disease.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1526-632X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
28
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
246-52
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12552039-Age Factors,
pubmed-meshheading:12552039-Aged,
pubmed-meshheading:12552039-Aged, 80 and over,
pubmed-meshheading:12552039-Alleles,
pubmed-meshheading:12552039-Alzheimer Disease,
pubmed-meshheading:12552039-Apolipoprotein E4,
pubmed-meshheading:12552039-Apolipoproteins E,
pubmed-meshheading:12552039-Brain,
pubmed-meshheading:12552039-Cognition Disorders,
pubmed-meshheading:12552039-Disease Progression,
pubmed-meshheading:12552039-Educational Status,
pubmed-meshheading:12552039-Female,
pubmed-meshheading:12552039-Genetic Predisposition to Disease,
pubmed-meshheading:12552039-Humans,
pubmed-meshheading:12552039-Linear Models,
pubmed-meshheading:12552039-Logistic Models,
pubmed-meshheading:12552039-Longitudinal Studies,
pubmed-meshheading:12552039-Male,
pubmed-meshheading:12552039-Memory Disorders,
pubmed-meshheading:12552039-Neuropsychological Tests,
pubmed-meshheading:12552039-Odds Ratio,
pubmed-meshheading:12552039-Risk Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
|
|
pubmed:affiliation |
Rush Alzheimer's Disease Center, Chicago, Illinois 60612, USA. dbennett@rush.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
